BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2017
View Archived Issues
Positive phase I/IIa data for jCell in retinitis pigmentosa
Read More
Izana Bioscience launches, obtains rights to Takeda's namilumab for ankylosing spondylitis
Read More
Myonexus Therapeutics secures financing to develop gene therapies for limb-girdle muscular dystrophy
Read More
Kyn Therapeutics completes series A financing
Read More
Vaccine to protect against H. influenzae type A licensed to InventVacc for manufacturing
Read More
New models of epileptic encephalopathy type 26 employ novel mutation
Read More
CHMP grants positive opinion to Cx601 for the treatment of perianal fistulas in Crohn's disease
Read More
Lysyl oxidase inhibitor from Pharmaxis shows promise in model of primary myelofibrosis
Read More
BioTheryX describes novel cereblon-binding small molecules
Read More
Jnana Therapeutics launches with series A financing to target metabolic genes
Read More
FDA lifts clinical hold on Alnylam Pharmaceuticals' fitusiran
Read More
Long non-coding RNA linked to lymph node metastasis in breast cancer
Read More
Pfizer launches Ibrance in Japan
Read More
EMA committee hands down positive opinion on burosumab for X-linked hypophosphatemia
Read More
Celgene and Cancer Research Technology enter drug discovery collaboration
Read More
Celltrion's trastuzumab biosimilar recommended for E.U. approval
Read More
EMA committee recommends approval of Ozempic for type 2 diabetes
Read More
Athenex begins IND process for oral eribulin
Read More
Phase Ib study of TG-02 in RAS-mutated colorectal cancer passes initial safety review
Read More
FDA grants priority review to Tagrisso sNDA in NSCLC
Read More
Horizon Discovery in agreement with Roche Diagnostics to support development of IHC assays
Read More
EMA committee recommends approval of Alkindi for pediatric adrenal insufficiency
Read More
Bristol-Myers Squibb initiates phase III study of BMS-986205 with nivolumab in advanced melanoma
Read More
Novel IRAK inhibitors discovered at Pharmacyclics
Read More
Chiesi patents neutrophil elastase inhibitors
Read More
DuoGel studied in phase I pharmacokinetic trial
Read More
AbbVie Sarl, Galapagos identify novel CFTR modulators
Read More
Ferring presents new angiotensin AT1 receptor antagonists
Read More
Bristol-Myers Squibb divulges novel Rho kinase 2 inhibitors
Read More